Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |